1. Home
  2. MSAI vs BCTX Comparison

MSAI vs BCTX Comparison

Compare MSAI & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSAI
  • BCTX
  • Stock Information
  • Founded
  • MSAI 1995
  • BCTX 2014
  • Country
  • MSAI United States
  • BCTX Canada
  • Employees
  • MSAI N/A
  • BCTX N/A
  • Industry
  • MSAI
  • BCTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSAI
  • BCTX Health Care
  • Exchange
  • MSAI Nasdaq
  • BCTX Nasdaq
  • Market Cap
  • MSAI 25.9M
  • BCTX 21.8M
  • IPO Year
  • MSAI N/A
  • BCTX N/A
  • Fundamental
  • Price
  • MSAI $1.34
  • BCTX $10.08
  • Analyst Decision
  • MSAI Strong Buy
  • BCTX Strong Buy
  • Analyst Count
  • MSAI 2
  • BCTX 1
  • Target Price
  • MSAI $2.75
  • BCTX $40.00
  • AVG Volume (30 Days)
  • MSAI 32.4M
  • BCTX 86.6K
  • Earning Date
  • MSAI 11-13-2025
  • BCTX 12-15-2025
  • Dividend Yield
  • MSAI N/A
  • BCTX N/A
  • EPS Growth
  • MSAI N/A
  • BCTX N/A
  • EPS
  • MSAI N/A
  • BCTX N/A
  • Revenue
  • MSAI $5,591,000.00
  • BCTX N/A
  • Revenue This Year
  • MSAI N/A
  • BCTX N/A
  • Revenue Next Year
  • MSAI $70.41
  • BCTX $380.95
  • P/E Ratio
  • MSAI N/A
  • BCTX N/A
  • Revenue Growth
  • MSAI N/A
  • BCTX N/A
  • 52 Week Low
  • MSAI $0.46
  • BCTX $6.00
  • 52 Week High
  • MSAI $3.33
  • BCTX $190.50
  • Technical
  • Relative Strength Index (RSI)
  • MSAI 58.44
  • BCTX 40.38
  • Support Level
  • MSAI $0.50
  • BCTX $11.75
  • Resistance Level
  • MSAI $2.40
  • BCTX $13.43
  • Average True Range (ATR)
  • MSAI 0.34
  • BCTX 1.12
  • MACD
  • MSAI 0.10
  • BCTX -0.50
  • Stochastic Oscillator
  • MSAI 44.21
  • BCTX 8.18

About MSAI Infrared Cameras Holdings Inc.

MultiSensor AI Holdings Inc build and deploy intelligent multi-sensing platforms incorporating edge and cloud software solutions that leverage artificial intelligence (AI). It is a provider of sensing systems built around high-resolution thermal imagers, visible and acoustic imagers, as well as vibration and laser spectroscopy sensors, that perceive and measure heat, sound, vibration, and gas in industrial assets and the surrounding environment, helping companies gain insight to protect and manage their most important assets and infrastructure. It also offers a wide range of form factors for its sensor devices, including, among other form factors, small to large handheld designs with built-in displays and controls, and fixed-mounted single- and multi-sensor camera sensor systems.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.

Share on Social Networks: